Two Fed moves hitting the wire right now — AML reform and the annual stress test results, and both matter for every bank name you're holding.

Two Fed moves hitting the wire right now — AML reform and the annual stress test results, and both matter for every bank name you're holding.

First — the Fed is opening a comment period on proposed amendments to bank anti-money laundering program requirements. Regulatory overhaul in motion. If you're sitting in financials, compliance cost structures are about to get stress-tested in a different way than whatever the Fed modeled. Watch the regionals hardest — they carry the most AML operational exposure relative to their size, and they don't have JPMorgan's compliance army to absorb it.

Second — the one traders are actually pricing right now — the Fed's annual stress test confirms large banks are well capitalized to absorb a severe recession scenario and keep lending. Headline pass. The big players cleared it. That green light historically opens the door to buyback authorizations and dividend hikes in the weeks that follow. But here's what management isn't leading with: passing a stress test tells you the floor held, not that the ceiling is moving. Read the capital return announcements when they drop — the delta between what they're authorized to return and what they actually commit to is where the real signal lives.

So you've got two data points landing in the same week. One says the rules are changing. One says the big players passed the test under the old rules. The question nobody on the earnings call will answer cleanly: does management use that stress test cover to get aggressive on capital returns before AML compliance costs show up in the operating expense line? Because those two things are on a collision course, and the timeline is not in their favor.

The numbers are the numbers. Management can spin. We don't.